Today: 19 July 2026
Browse Category

Cannabis Industry 7 December 2025 - 16 June 2026

IM Cannabis Stock Surges as Traders Weigh Nasdaq Listing and Dilution Risks

IM Cannabis Stock Surges as Traders Weigh Nasdaq Listing and Dilution Risks

IM Cannabis Corp. shares are trading heavy again. IMCC closed at $0.2610 on June 15, up 12.31% on Nasdaq, and was last seen at $0.3491 in the premarket at 6:43 a.m. ET on June 16, according to StockAnalysis market data. The stock is moving without any fresh company updates. The company’s investor-relations site and SEC filings show the last events were a June 9 Form F-3 resale registration and a related 6-K and the June 3 financing filing. Nothing new has hit in the past day or so.
16 June 2026
···
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Cannabis Corp. is seeing the kind of attention U.S. cannabis players have long tried to get: a listing on a major U.S. exchange, a new ticker, and a signal it might return capital. Shares are now trading on the NYSE as TRLV. The stock was quoted near $11.78 Thursday morning after ending its NYSE debut at $11.50. The focus now is whether being on a bigger exchange and having new access might pull in steadier demand for the shares, not just more cannabis buzz.
11 June 2026
··
Canada Stock Market Today: TSX Slips at Midday as Financials Weigh, While Cannabis and Commodities Stay in Focus (Dec. 17, 2025)

Canada Stock Market Today: TSX Slips at Midday as Financials Weigh, While Cannabis and Commodities Stay in Focus (Dec. 17, 2025)

Canada’s stock market is struggling to hold early momentum on Wednesday as the heavyweight financial sector drags on the Toronto Stock Exchange, even while commodity-linked and cannabis stocks remain in the spotlight. By late morning, the S&P/TSX Composite Index had moved into negative territory after earlier edging higher on a rebound in oil and a fresh surge in precious metals. CityNews Halifax+1
17 December 2025
··
Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands, Inc. stock is back in the spotlight on December 17, 2025, as cannabis stocks react—again—to fast-moving headlines around potential U.S. federal marijuana rescheduling. In the latest session, TLRY traded around $13.94, up roughly 27% on the day, after swinging between about $10.32 and $14.54—a reminder that Tilray remains one of the market’s most headline-sensitive, momentum-driven names.
17 December 2025
···
S&P/TSX Composite Today: Oil Slips Toward $60, Cannabis Surges, and Macklem’s Speech Looms for After-the-Bell Trade (Dec. 16, 2025)

S&P/TSX Composite Today: Oil Slips Toward $60, Cannabis Surges, and Macklem’s Speech Looms for After-the-Bell Trade (Dec. 16, 2025)

Canada’s S&P/TSX Composite index was lower in late-morning trading Tuesday, weighed down by a sharp slide in energy names as crude prices weakened on renewed optimism around Russia–Ukraine peace talks. At around 11:26 a.m. ET, the benchmark was about 31,324 points, down roughly 0.5% on a delayed quote—putting the TSX on pace for a third straight daily decline, even after a powerful 2025 run that has left the index up about 26.7% year to date. MarketScreener+1
16 December 2025
··
Tilray Brands (TLRY) Stock News Today: Cannabis Rally Cools as Trump Schedule III Speculation Fuels Volatility

Tilray Brands (TLRY) Stock News Today: Cannabis Rally Cools as Trump Schedule III Speculation Fuels Volatility

Tilray Brands, Inc. is back in the spotlight on December 15 after one of its biggest momentum bursts in years—followed by an equally fast reality check. The stock’s latest swing is being driven less by quarterly fundamentals and more by a single macro catalyst: growing expectations that President Donald Trump could move to ease federal marijuana restrictions by pushing a reclassification of cannabis to Schedule III.
15 December 2025
··
Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Brands is back at the center of the cannabis market’s biggest catalyst in years: growing expectations that President Donald Trump could move to ease federal marijuana restrictions by pushing a reclassification of cannabis to Schedule III. On Monday, December 15, 2025, the optimism spilled into global trading, with cannabis names extending last week’s explosive rally as investors tried to price what a Schedule III world could mean for taxes, banking access, and institutional participation. Reuters+1
15 December 2025
····
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation stock is back in the spotlight on December 15, 2025, as the cannabis sector reacts to a fresh wave of reporting that President Donald Trump may soon move to ease federal marijuana restrictions—specifically by reclassifying cannabis as a Schedule III drug under U.S. law. In early European trading on Monday, Canopy Growth led the group, jumping as much as 17.9% and extending a dramatic rally from the prior session. Reuters
15 December 2025
··
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

December 12, 2025 — Cronos Group Inc. is back in the spotlight after cannabis stocks jumped broadly into early trading on reports that the Trump administration could pursue a major easing of federal marijuana restrictions — specifically, a push to reclassify marijuana from Schedule I to Schedule III .Reuters+ 1
12 December 2025
··
US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

SEO summary: Here are the biggest US stock market premarket gainers today and the news driving them, including Lululemon’s earnings and CEO transition, a cannabis-stock surge tied to marijuana rescheduling headlines, and earnings-driven jumps in Mitek and Quanex. Nasdaq+4StockAnalysis+4Reuters+4
12 December 2025
·············
Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis Inc. is ending 2025 in a very different place from where it started. After years of restructuring, the company has become a highly focused global medical cannabis business, with new partnerships in Australia, expanding operations in Europe, and back‑to‑back quarters of record medical revenue.
7 December 2025
···
1 2
Go toTop